2022
Cancer-Associated Hypercalcemia. Reply.
Guise TA, Wysolmerski JJ. Cancer-Associated Hypercalcemia. Reply. New England Journal Of Medicine 2022, 386: 2540. PMID: 35767456, DOI: 10.1056/nejmc2206287.Peer-Reviewed Original ResearchCancer-Associated Hypercalcemia
Guise TA, Wysolmerski JJ. Cancer-Associated Hypercalcemia. New England Journal Of Medicine 2022, 386: 1443-1451. PMID: 35417639, DOI: 10.1056/nejmcp2113128.Peer-Reviewed Original Research
1994
HYPERCALCEMIA OF MALIGNANCY: The Central Role of Parathyroid Hormone-Related Protein
Wysolmerski J, Broadus A. HYPERCALCEMIA OF MALIGNANCY: The Central Role of Parathyroid Hormone-Related Protein. Annual Review Of Medicine 1994, 45: 189-200. PMID: 8198376, DOI: 10.1146/annurev.med.45.1.189.Peer-Reviewed Original ResearchConceptsLocal osteolytic hypercalcemiaMalignancy-associated hypercalcemiaHormone-related protein gene expressionParathyroid hormone-related proteinCommon metabolic complicationCommon clinical problemLocal paracrine factorsHormone-related proteinParathyroid hormone-related protein gene expressionHHM syndromeMetabolic complicationsHumoral hypercalcemiaParathyroid hormoneBone resorptionHypercalcemiaParacrine roleClinical problemParacrine factorsSyndromeRecent dataProtein gene expressionHormoneMolecular mechanismsGene expressionComplications